Alessandro Rambaldi, MD
A.O. Ospedale Papa Giovanni XXIII
7
7
1
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Giuseppe Remuzzi, MD
A.O. Ospedale Papa Giovanni XXIII
Shared therapeutic areas:
Worked with same sponsors:
Giovanni Rota, MD
A.O. Ospedale Papa Giovanni XXIII
Shared therapeutic areas:
Worked with same sponsors:
Norberto Perico, MD
Istituto Di Ricerche Farmacologiche Mario Negri
Shared therapeutic areas:
Worked with same sponsors:
Federica Casiraghi
Istituto Di Ricerche Farmacologiche Mario Negri
Shared therapeutic areas:
Worked with same sponsors:
Martino Introna, MD
Laboratorio G. Lanzani, Bergamo, Italy
Shared therapeutic areas:
Worked with same sponsors:
Stefano Fagiuoli, MD
A.O. Ospedale Papa Giovanni XXIII
Shared therapeutic areas:
Worked with same sponsors:
tiziano oldoni, MD
Italfarmaco
Shared therapeutic areas:
Worked with same sponsors:
Norberto Perico, MD
IRCCS-Istituto di Ricerche Farmacologiche M. Negri
Shared therapeutic areas:
Worked with same sponsors:
Martino Introna, MD
Laboratorio G.Lanzani, Bergamo, Italy
Shared therapeutic areas:
Worked with same sponsors:
Antonio Pinna, MD
Policlinico S. Orsola Bologna, Italy
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant
Bergamo Lymphoid Cancer Registry
Mesenchymal Stromal Cells in Kidney Transplant Recipients
Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases
Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease
MSC Therapy in Liver Transplantation
MSC and Kidney Transplant Tolerance (Phase A)
All 7 trials loaded